Publications by authors named "Stuart Hogarth"

Claim this Profile
M
Mapping the patent landscape of cancer diagnostics.
Mateo Aboy, Kathleen Liddell, Cristina Crespo, Matthew Jordan, Stuart Hogarth

Nat Biotechnol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis, treatment decision-making and value: A qualitative exploration of the emerging role of breast cancer prognostic assays.
Gillian Parker, Stuart Hogarth, Jennifer Fishman, Fiona A Miller

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GRAIL-Galleri: why the special treatment?
Clare Turnbull, Nicholas Wald, Richard Sullivan, Paul Pharoah, Richard S Houlston, Stuart Hogarth

Lancet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industry involvement in evidence production for genomic medicine: A bibliometric and funding analysis of decision impact studies.
Gillian Parker, Sarah Hunter, Stuart Hogarth, Fiona A Miller

PLoS One· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory niches: Diagnostic reform as a process of fragmented expansion. Evidence from the UK 1990-2018.
Stuart Hogarth, Olga Löblová

Soc Sci Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary perspectives on the regulation of diagnostic technologies.
Stuart Hogarth, Fiona A Miller, Steve Sturdy

Soc Sci Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Half a Century of Wilson & Jungner: Reflections on the Governance of Population Screening.
Steve Sturdy, Fiona Miller, Stuart Hogarth, Natalie Armstrong, Pranesh Chakraborty

Wellcome Open Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to C.D. Richter.
Johnathon Liddicoat, Kathleen Liddell, Arlie H McCarthy, Stuart Hogarth, Mateo Aboy

Eur J Hum Genet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responses to "Health Canada needs to act on laboratory-developed diagnostics".
Kelly Holloway, Fiona A Miller, François Rousseau, Alberto Gutierrez, Stuart Hogarth

CMAJ· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Canada needs to act on laboratory-developed diagnostics.
Kelly Holloway, Fiona A Miller, François Rousseau, Alberto Gutierrez, Stuart Hogarth

CMAJ· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continental drift? Do European clinical genetic testing laboratories have a patent problem?
Johnathon Liddicoat, Kathleen Liddell, Arlie H McCarthy, Stuart Hogarth, Mateo Aboy

Eur J Hum Genet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dangerous diagnostics? Regulatory reform in the genomic era.
Kelly Holloway, Fiona A Miller, Alberto Gutierrez, Stuart Hogarth

BMJ· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoliberal technocracy: explaining how and why the US Food and Drug Administration has championed pharmacogenomics.
Stuart Hogarth

Soc Sci Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
Timothy Caulfield, Jim Evans, Amy McGuire, Christopher McCabe, Tania Bubela, Stuart Hogarth

PLoS Biol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genes, genes, genes.
Stuart Hogarth, Richard Sullivan

Lancet Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker patents for diagnostics: problem or solution?
Michael M Hopkins, Stuart Hogarth

Nat Biotechnol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized medicine: renewing the social science research agenda.
Stuart Hogarth, Michael Hopkins, Alex Faulkner

Per Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.
Stuart Hogarth, Michael M Hopkins, Victor Rodriguez

Sociol Health Illn· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of direct-to-consumer clinical genetic tests.
Felix W Frueh, Henry T Greely, Robert C Green, Stuart Hogarth, Sue Siegel

Nat Rev Genet· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.
Frauke Becker, Carla G van El, Dolores Ibarreta, Eleni Zika, Stuart Hogarth

Eur J Hum Genet· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regenerative medicine in Europe: global competition and innovation governance.
Stuart Hogarth, Brian Salter

Regen Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic tests.
Paula M Saukko, Matthew Reed, Nicky Britten, Stuart Hogarth

Soc Sci Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.
Stuart Hogarth, Gail Javitt, David Melzer

Annu Rev Genomics Hum Genet· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Closing the gaps--enhancing the regulation of genetic tests using responsive regulation.
Stuart Hogarth, Kathy Liddell, Tom Ling, Simon Sanderson, Ron Zimmern

Food Drug Law J· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis